Pharmaceuticals

US FDA approves Bayer’s haemophilia therapy Kovaltry

18 Mar 2016

More drug bans coming: 1,200 FDCs under scanner

18 Mar 2016

Delaware jury rules in favour of Amgen in patent infringement case

17 Mar 2016

US warns drugmaker Emcure for ‘fudging’ test results

17 Mar 2016

Biocon inks co-development and marketing pact with Mexican co for rh-insulin

17 Mar 2016

British respiratory drug maker Vectura to buy Skyepharma for $621 mn

17 Mar 2016

Jan Aushadhi makes available 88 essential drugs and other medical products

16 Mar 2016

P&G follows Pfizer, Abbot, ends sale of cold remedy

15 Mar 2016

Valeant Pharmaceuticals cuts revenue forecast by 12%

15 Mar 2016

India bans Pfizer, Abbot cough syrups; shares tank

14 Mar 2016

The centre has banned Pfizer’s Corex and Abbot Laboratories’ Phensedyl after a panel of experts found the codeine-based drugs had ‘no therapeutic justification’ and were leading to addiction as well as smuggling

View details about the software product Informachine News Trackers

Latest articles

Sigma Advanced to acquire UK aerospace supplier Bromford for ₹153 crore

 Sigma Advanced to acquire UK aerospace supplier Bromford for ₹153 crore

Akasa Air plans ₹1,050 crore fundraising to support growth amid higher costs

 Akasa Air plans ₹1,050 crore fundraising to support growth amid higher costs

AI startup Reflection signs over $1 billion computing deal with Nebius

 AI startup Reflection signs over $1 billion computing deal with Nebius

Tata Power explores $450 million overseas loan for business operations

 Tata Power explores $450 million overseas loan for business operations

TCS wins technology contract for New York JFK Airport’s $19 billion terminal

 TCS wins technology contract for New York JFK Airport’s $19 billion terminal

South Korean firms unveil $195 billion investment in AI and advanced industries

 South Korean firms unveil $195 billion investment in AI and advanced industries

HCLTech wins $1.14 billion AI transformation deal with European client

 HCLTech wins $1.14 billion AI transformation deal with European client

Microsoft launches Frontier to help enterprises accelerate AI adoption

 Microsoft launches Frontier to help enterprises accelerate AI adoption

AstraZeneca signs up to $1.77 billion CSPC deal for kidney disease drugs

 AstraZeneca signs up to $1.77 billion CSPC deal for kidney disease drugs